Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

Jillian’s Story

This was my first experience at being involved in any sort of research. If I get the opportunity again, I would definitely put my hand up after the wonderful experience I had with your team. Thank you so much to Emma and all your team for making me feel so welcome. Jillian Meet Jillian, retired […]

Breaking Ground in Paediatric Rare Disease Research

Wesley Research Institute is home to a groundbreaking trial using triheptanoin, a dietary fat, to treat Ataxia-Telangiectasia (A-T), a rare degenerative neurological disorder. This trial has shown promising results, with observed improvements in neurology scales and cellular biomarkers indicating the treatment’s effectiveness.

World-First ‘Back to the Future’ Research Set To Boost Pandemic Protection

A world-first research project by two Queensland professors is set to offer a blueprint for developing more effective vaccines and therapies specifically tailored to safeguard the health of children and young adults in times of global health crises. Spearheaded by Professor John Fraser, Dr Arutha Kulasinghe and Associate Professor Kirsty Short, this pioneering study, funded […]

1 2 3 … 12 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis